§ Claim under review · Capability
"The DNA enzyme that turned into CRISPR was hiding in bacteria for billions of years before scientists noticed it. Now an AI may have spotted its cousin in 21 hours. Anthropic gave Claude a single prompt: search a massive DNA database for enzymes that copy RNA into DNA. About 950 Claude agents worked in parallel. They combed through 200,000+ enzymes, narrowed them to 3,500 candidates, and wrote up the 20 most promising. One agent, reading raw DNA from a virus that infects bacteria, noticed something odd: a long, evenly spaced repeating pattern sitting right next to an enzyme. It looked a lot like a CRISPR array. Anthropic named the system ART. Its own lab has confirmed the system is real and active. CRISPR co-inventor Feng Zhang reviewed the preprint and called it genuinely intriguing. The catch? Nobody knows what ART actually does yet... But the speed is the story. Anthropic says this kind of search can take human experts weeks to months."
Verdict
Partially accurate but misleading
Confidence
MediumSummary
This post is mostly a faithful retelling of Anthropic's own announcement from September 23, 2026, and the striking numbers in it, about 950 agents, 21 hours, 200,000 enzymes narrowed to 3,500 then 20, all come straight from Anthropic's blog. The Feng Zhang quote is real and accurately reproduced. Two things are off. First, the post says Anthropic's lab confirmed the system is "real and active," but the preprint states the opposite about activity: the lab showed the repeat array gets turned into short RNAs, and explicitly says it has not shown the enzyme is active or that it acts on those RNAs. Second, the post leaves out the detail that most complicates the speed story, which is that Anthropic reran the same campaign ten more times and every rerun missed the array. All of this evidence comes from the company that makes the AI, in a preprint that has not been peer reviewed and that nobody outside Anthropic has replicated. What ART actually does remains genuinely unknown, which the post does say.
The readings
key figures from the evidenceagent sessions used in 21-hour search campaign, per Anthropic
fixed-test success rate describing array when given DNA directly
Why this verdict
Evidence
The underlying event is real and the numbers in the post come almost verbatim from Anthropic's own announcement. Anthropic states that Claude agents gathered over 200,000 RTs, picked out 3,500 new candidate systems, and narrowed those to the 20 most-compelling candidates that they analyzed to produce human-readable reports, and that for an expert scientist this type of analysis can take weeks to months of work.
Anthropic says it gave Claude a prompt to search through a massive database of DNA sequences for interesting new examples of RTs, that its involvement was limited to the initial prompt and the lab work, and that after 21 hours spent searching by roughly 950 agents using 210 million tokens, one agent spotted a repeating pattern of DNA sequences.
On the system itself: Anthropic describes ART as found mainly in bacteriophages and consisting of three parts, the RT, a partner gene beside it, and a long array of evenly spaced DNA repeat sequences whose layout resembles a CRISPR array, and says its first experiments show the ART array is also expressed as a set of distinct short RNAs, with further experiments underway to determine how ART works.
The preprint's own limits, as reported by outlets that read it: ART arrays hold 3 to 21 copies of a short repeat, none has the cas genes that CRISPR systems carry nearby, and in lab tests Anthropic's scientists found the array is read out as a set of distinct short RNAs; the preprint says the team has not yet shown that the enzyme is active, or that it works on these RNAs.
Anthropic ran the same campaign ten more times, no rerun read the DNA upstream of the enzyme, and all ten missed the array.
The authors attribute this to the size of the search and the agents' unpredictable behaviour, and in fixed tests Anthropic's four most capable models described the array in at least 90% of attempts when given the DNA directly.
On novelty: researchers had already recorded this particular enzyme in a jumbo phage, earlier studies appear to have overlooked the system's defining features, and Claude seems to be the first to spot them: a partner protein whose function nobody knows, and a long array of evenly spaced DNA repeats laid out much like a CRISPR array.
The Zhang quote is real and complete as published: "This is an exciting example of how AI agents can contribute to biological discovery. The identification of RNA-repeat arrays associated with reverse transcriptases is genuinely intriguing and merits further investigation."
Findings
✓ What's accurate 6
- The event happened and the funnel numbers are quoted correctly from Anthropic's announcement: single initial prompt, roughly 950 agents, about 21 hours, 200,000+ RTs, ~3,500 candidates, 20 write-ups.
- The system is named ART and was found in bacteriophages; it does combine an RT, an accessory gene of unknown function, and an evenly spaced repeat array resembling a CRISPR array.
- The "one agent reading raw DNA noticed a repeating pattern" description matches Anthropic's account.
- The Feng Zhang quote is accurate and was published by Anthropic alongside the post.
- The "weeks to months" line is correctly attributed to Anthropic rather than presented as independent fact.
- The post's own caveat, that nobody knows what ART does, matches the preprint and the vendor blog.
≈ What's misleading 6
- **Exaggeration:** "Its own lab has confirmed the system is real and active." The preprint says the opposite about activity. Anthropic's lab showed the repeat array is transcribed into discrete short RNAs; the preprint says the team has not yet shown that the enzyme is active, or that it works on these RNAs. "Active" is the single word a reader will take as functional validation, and it is precisely what has not been demonstrated.
- **Omitted qualifier:** the post's headline framing, "spotted its cousin in 21 hours," omits that the result did not reproduce. All ten reruns of the same campaign missed the array. A one-off hit in a stochastic search is a different capability claim from a 21-hour discovery pipeline, and the omission is what converts a lucky run into "the speed is the story."
- **Marketing as evidence:** every load-bearing number, the discovery narrative, and the only lab validation come from the vendor whose model is the subject of the claim, published on its own channels in an unrefereed preprint. No independent evaluator has checked the campaign or the bench work. The post presents this as settled reporting rather than as a vendor self-report.
- **Capability extrapolation:** "the DNA enzyme that turned into CRISPR... now an AI may have spotted its cousin" implies evolutionary or functional kinship with CRISPR. The resemblance is architectural only, and none of the ART systems has the cas genes that CRISPR systems carry nearby. The opening sentence is also garbled as biology: CRISPR is not a "DNA enzyme," and CRISPR arrays plus Cas proteins are a bacterial immune system, not an enzyme that "turned into" a tool.
- **Omitted qualifier:** the post implies the enzyme itself was the find. The particular enzyme had already been recorded in a jumbo phage; what earlier studies overlooked were the array and the partner protein. Claude's contribution was recognizing the system, not the enzyme.
- **Scale conflation (minor):** "Claude" unpinned. The campaign is reported as having run on a specific model, and "Claude" as a family name spans many versions with very different agentic behavior.
? What's uncertain 5
- I did not retrieve the preprint PDF itself. All statements about its contents here are as reported by named outlets that did read it, and the vendor blog. The preprint's exact wording on activity, reruns, and repeat counts is therefore secondhand in this report.
- "950 agents worked in parallel" cannot be confirmed as simultaneous concurrency. The preprint figure reported is 949 agent *sessions* over 21.5 hours, which is not the same as 950 agents running at once.
- Whether ART is a defense system, a mobile element, a future editing tool, or noise is entirely open. No party claims otherwise.
- Whether the small-RNA result holds up under independent replication is untested. It has existed publicly for roughly one day as of 2026-09-24.
- Whether the previously published sequence data reanalysis and the new E. coli expression experiments are being conflated in secondary coverage is not fully resolvable without the PDF.
Sources
5 of 7 linked to recordsAnthropic newsroom post, "Claude discovers a novel enzyme system" (vendor channel of record; page content read in excerpt via search index, not full page load)
Anthropic technical report / preprint, "Autonomous AI agents discover reverse transcriptases with tandem repeat arrays"
The Next Web, detailed reporting quoting the preprint (agent-session counts, repeat counts, failed reruns, activity caveat)
Interesting Engineering coverage
Analytics India Magazine coverage
StreetInsider / Investing.com wire summaries
Kingy AI analysis citing the technical report's internal figures